Browse by Aston Author

Up a level
Export as [feed] Atom [feed] RSS
Group by: Item Type | Date | No Grouping
Number of items: 63.

Article

Mirza, Kamran A., Luo, Menghua, Pereira, Suzette, Voss, Anne, Das, Tapas and Tisdale, Michael J. (2016). In vitro assessment of the combined effect of eicosapentaenoic acid, green tea extract and curcumin C3 on protein loss in C2C12 myotubes. In Vitro Cellular and Developmental Biology: Animal, 52 (8), 838–845.

Mirza, Kamran A., Pereira, Suzette L., Edens, Neile K. and Tisdale, Michael J. (2014). Attenuation of muscle wasting in murine C2C12myotubes by epigallocatechin-3-gallate. Journal of Cachexia, Sarcopenia and Muscle, 5 (4), pp. 339-345.

Mirza, K.A. and Tisdale, M.J. (2014). Functional identity of receptors for proteolysis-inducing factor on human and murine skeletal muscle. British Journal of Cancer, 111 (5), pp. 903-908.

Russell, Steven T. and Tisdale, Michael J. (2012). Role of β-adrenergic receptors in the oral activity of zinc-α2-glycoprotein (ZAG). Endocrinology, 153 (10), pp. 4696-4704.

Russell, Steven T. and Tisdale, Michael J. (2012). Role of β-adrenergic receptors in the anti-obesity and anti-diabetic effects of zinc-α2-glycoprotien (ZAG). BBA - Molecular and Cell Biology of Lipids, 1821 (4), pp. 590-599.

Tisdale, Michael (2011). Decreased NADPH oxidase expression and antioxidant activity in cachectic skeletal muscle. Journal of Cachexia, Sarcopenia and Muscle, 2 (3), 181–188.

Mirza, Kamran, Wyke, Stacey M. and Tisdale, Michael (2011). Attenuation of muscle atrophy by an N-terminal peptide of the receptor for proteolysis-inducing factor (PIF). British Journal of Cancer, 105 (1), pp. 83-88.

Russell, Steven and Tisdale, Michael (2011). Studies on the anti-obesity activity of zinc-α2-glycoprotein in the rat. International Journal of Obesity, 35 (5), pp. 658-665.

Russell, Steven and Tisdale, Michael (2011). Studies on the antiobesity effect of zinc-α2-glycoprotein in the ob/ob mouse. International Journal of Obesity, 35 (3), pp. 345-354.

Tisdale, Michael J. (2010). Reversing cachexia. Cell, 142 (4), pp. 511-512.

Russell, Steven, Siren, Pontus M.A., Siren, Matus J. and Tisdale, Michael (2010). The role of zinc in the anti-tumour and anti-cachectic activity of D-myo-inositol 1,2,6-triphosphate. British Journal of Cancer, 102 (5), 833–836.

Russell, Steve T., Siren, P.M.A., Siren, M.J. and Tisdale, Michael J. (2009). Attenuation of skeletal muscle atrophy in cancer cachexia by d-myo-inositol 1,2,6-triphosphate. Cancer Chemotherapy and Pharmacology, 64 (3), pp. 517-527.

Russell, Steve T., Eley, Helen L., Wyke, Stacey M. and Tisdale, Michael J. (2008). Involvement of phosphoinositide 3-kinase and Akt in the induction of muscle protein degradation by proteolysis-inducing factor. Biochemical Journal, 409 (Part 3), pp. 751-759.

Eley, H.L., Skipworth, R.J.E., Deans, D.A.C., Fearon, K.C.H. and Tisdale, Michael J. (2008). Increased expression of phosphorylated forms of RNA-dependent protein kinase and eukaryotic initiation factor 2 alpha may signal skeletal muscle atrophy in weight-losing cancer patients. British Journal of Cancer, 98 (2), pp. 443-449.

Yano, Claudia L., Ventrucci, Gislaine, Field, William N., Tisdale, Michael J. and Gomes-Marcondes, Maria Cristina C. (2008). Metabolic and morphological alterations induced by proteolysis-inducing factor from Walker tumour-bearing rats in C2C12 myotubes. BMC Cancer, 8 (24), 24-.

Eley, H., Russell, S.T. and Tisdale, M.J. (2007). Attenuation of muscle atrophy in a murine model of cachexia by inhibition of the dsRNA-dependent protein kinase. British Journal of Cancer, 96 (8), pp. 1216-1222.

Bhogal, Ameek S., Lorite, Maria L. and Tisdale, Michael J. (2006). Changes in nucleic acid and protein levels in atrophying skeletal muscle in cancer cachexia. Anticancer Research, 26 (6B), pp. 4149-4154.

Bing, C., Russell, S., Becket, E., Pope, M., Tisdale, M.J., Trayhurn, P. and Jenkins, J.R. (2006). Adipose atrophy in cancer cachexia:morphologic and molecular analysis of adipose tissue in tumour-bearing mice. British Journal of Cancer, 95 (8), pp. 1028-1037.

Deans, D.A.C., Wigmore, S.J., Gilmour, H., Tisdale, Michael J., Fearon, Kenneth C.H. and Ross, J.A. (2006). Expression of the proteolysis-inducing factor core peptide mRNA is upregulated in both tumour and adjacent normal tissue in gastro-oesophageal malignancy. British Journal of Cancer, 94 (5), pp. 731-736.

Khal, J., Hine, A.V., Fearon, K.C.H., Dejong, C.H.C. and Tisdale, M.J. (2005). Increased expression of proteasome subunits in skeletal muscle of cancer patients with weight loss. International Journal of Biochemistry and Cell Biology, 37 (10), pp. 2196-2206.

Khal, J., Wyke, S.M., Russell, Steve T., Hine, Anna V. and Tisdale, Michael J. (2005). Expression of the ubiquitin-proteasome pathway and muscle loss in experimental cancer cachexia. British Journal of Cancer, 93 (7), pp. 774-780.

Sanders, P.M., Russell, S.T. and Tisdale, M.J. (2005). Angiotensin II directly induces muscle protein catabolism through the ubiquitin-proteasome proteolytic pathway and may play a role in cancer cachexia. British Journal of Cancer, 93 (4), pp. 425-434.

Smith, Helen J., Khal, Jwan and Tisdale, Michael J. (2005). Downregulation of ubiquitin-dependent protein degradation in murine myotubes during hyperthermia by eicosapentaenoic acid. Biochemical and Biophysical Research Communications, 332 (1), pp. 83-88.

Wyke, Stacey M. and Tisdale, Michael J. (2005). NF-κB mediates proteolysis-inducing factor induced protein degradation and expression of the ubiquitin-proteasome system in skeletal muscle. British Journal of Cancer, 92 (4), pp. 711-721.

Russell, Steve T. and Tisdale, Michael J. (2005). The role of glucocorticoids in the induction of zinc-α2-glycoprotein expression in adipose tissue in cancer cachexia. British Journal of Cancer, 92 (5), pp. 876-881.

Chand, Anita, Wyke, Stacey M. and Tisdale, Michael J. (2005). Effect of cancer cachexia on the activity of tripeptidyl-peptidase II in skeletal muscle. Cancer Letters, 218 (2), pp. 215-222.

Beck, S.A. and Tisdale, M.J. (2004). Effect of cancer cachexia on triacylglycerol/fatty acid substrate cycling in white adipose tissue. Lipids, 39 (12), pp. 1187-1189.

Smith, Helen J., Wyke, Stacey M. and Tisdale, Michael J. (2004). Mechanism of the attenuation of proteolysis-inducing factor stimulated protein degradation in muscle by β-hydroxy-β-methylbutyrate. Cancer Research, 64 (23), pp. 8731-8735.

Tisdale, Michael J. (2004). Tumor-host interactions. Journal of Cellular Biochemistry, 93 (5), pp. 871-877.

Wyke, S.M., Russell, Steve T. and Tisdale, Michael J. (2004). Induction of proteasome expression in skeletal muscle is attenuated by inhibitors of NF-κB activation. British Journal of Cancer, 91 (9), pp. 1742-1750.

Lattmann, Eric, Kinchington, Derek, Dunn, Simon, Singh, Harjit, Ayuko, Washington O. and Tisdale, Michael J. (2004). Cytotoxicity of 3,4-dihalogenated 2(5H)-furanones. Journal of Pharmacy and Pharmacology, 56 (9), pp. 1163-1170.

Wynter, Michael P., Russell, Steve T. and Tisdale, Michael J. (2004). Effect of n-3 fatty acids on the antitumour effects of cytotoxic drugs. In Vivo, 18 (5), pp. 543-548.

Smith, Helen J., Greenberg, N.A. and Tisdale, Michael J. (2004). Effect of eicosapentaenoic acid, protein and amino acids on protein synthesis and degradation in skeletal muscle of cachectic mice. British Journal of Cancer, 91 (2), pp. 408-412.

Smith, Helen J., Wyke, S.M. and Tisdale, Michael J. (2004). Role of protein kinase C and NF-kappa B in proteolysis-inducing factor-induced proteasome expression in C2C12 myotubes. British Journal of Cancer, 90 (9), pp. 1850-1857.

Sanders, P.M. and Tisdale, Michael J. (2004). Role of lipid-mobilising factor (LMF) in protecting tumour cells from oxidative damage. British Journal of Cancer, 90 (6), pp. 1274-1278.

Bing, Chen, Bao, Yi, Jenkins, John, Sanders, Paul, Manieri, Monia, Cinti, Saverio, Tisdale, Michael J. and Trayhurn, Paul (2004). Zinc-α2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia. Proceedings of the National Academy of Sciences, 101 (8), pp. 2500-2505.

Smith, Helen J. and Tisdale, Michael J. (2003). Signal transduction pathways involved in proteolysis-inducing factor induced proteasome expression in murine myotubes. British Journal of Cancer, 89 (9), pp. 1783-1788.

Fearon, K.C.H., von Meyenfeldt, M.F., Moses, A.G.W., van Geenen, R., Roy, A., Gouma, D.J., Giacosa, A., Van Gossum, A., Bauer, J., Barber, M.D., Aaronson, N.K., Voss, A.C. and Tisdale, Michael J. (2003). Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia:A randomised double blind trial. Gut, 52 (10), pp. 1479-1486.

Whitehouse, A.S. and Tisdale, Michael J. (2003). Increased expression of the ubiquitin-proteasome pathway in murine myotubes by proteolysis-inducing factor (PIF) is associated with activation of the transcription factor NF-kappa B. British Journal of Cancer, 89 (6), pp. 1116-1122.

Lattmann, Eric, Ayuko, Washington O., Kinchinaton, Derek, Langley, Chris A., Singh, Harjit, Karimi, Leila and Tisdale, Michael J. (2003). Synthesis and evaluation of 5-arylated 2(5H)-furanones and 2-arylated pyridazin-3(2H)-ones as anti-cancer agents. Journal of Pharmacy and Pharmacology, 55 (9), pp. 1259-1265.

Whitehouse, A.S., Khal, J. and Tisdale, Michael J. (2003). Induction of protein catabolism in myotubes by 15(S)-hydroxyeicosatetraenoic acid through increased expression of the ubiquitin-proteasome pathway. British Journal of Cancer, 89 (4), pp. 737-745.

Simpson, Julie, Forrester, Rebecca, Tisdale, Michael J., Billington, David C. and Rathbone, Daniel L. (2003). Effect of catechol derivatives on cell growth and lipoxygenase activity. Bioorganic and Medicinal Chemistry Letters, 13 (15), pp. 2435-2439.

Wang, Zejing, Corey, Eva, Hass, G. Michael, Higano, Celestia S., True, Lawrence D., Wallace, David, Tisdale, Michael J. and Vessella, Robert L. (2003). Expression of the human cachexia-associated protein (HCAP) in prostate cancer and in a prostate cancer animal model of cachexia. International Journal of Cancer, 105 (1), pp. 123-129.

Smith, H.J. and Tisdale, M.J. (2003). Induction of apoptosis by a cachectic-factor in murine myotubes and inhibition by eicosapentaenoic acid. Apoptosis, 8 (2), pp. 161-169.

Tisdale, Michael J. (2003). The 'cancer cachectic factor'. Supportive care in cancer, 11 (2), pp. 73-78.

Tisdale, Michael J. (2002). Cachexia in cancer patients. Nature Reviews: Cancer, 2 (11), pp. 862-871.

Gomez-Ambrosi, J., Zabalegui, N., Bing, C., Tisdale, Michael J., Trayhurn, P. and Williams, G. (2002). Weight loss in tumour-bearing mice is not associated with changes in resistin gene expression in white adipose tissue. Hormone and Metabolic Research, 34 (11-12), pp. 674-677.

Russell, S.T. and Tisdale, M.J. (2002). Effect of a tumour-derived lipid-mobilising factor on glucose and lipid metabolism in vivo. British Journal of Cancer, 87 (5), pp. 580-584.

Tisdale, Michael J. (2002). Biochemical mechanisms of cellular catabolism. Current Opinion in Clinical Nutrition and Metabolic Care, 5 (4), pp. 401-405.

Gomes-Marcondes, Maria Cristina C. and Tisdale, Michael J. (2002). Induction of protein catabolism and the ubiquitin-proteasome pathway by mild oxidative stress. Cancer Letters, 180 (1), pp. 69-74.

Gomes-Marcondes, Maria C.C., Smith, Helen J., Cooper, J.C. and Tisdale, Michael J. (2002). Development of an in-vitro model system to investigate the mechanism of muscle protein catabolism induced by proteolysis-inducing factor. British Journal of Cancer, 86 (10), pp. 1628-1633.

Bing, C., Russell, S.T., Beckett, E.E., Collins, P., Taylor, S., Barraclough, R., Tisdale, M.J. and Williams, G. (2002). Expression of uncoupling proteins-1,-2 and-3 mRNA is induced by an adenocarcinoma-derived lipid-mobilizing factor. British Journal of Cancer, 86 (4), pp. 612-618.

Russell, Steve T., Hirai, K. and Tisdale, Michael J. (2002). Role of β3-adrenergic receptors in the action of a tumour lipid mobilizing factor. British Journal of Cancer, 86 (3), pp. 424-428.

Bing, C., Taylor, S., Tisdale, Michael J. and Williams, G. (2001). Cachexia in MAC16 adenocarcinoma:Suppression of hunger despite normal regulation of leptin, insulin and hypothalamic neuropeptide Y. Journal of Neurochemistry, 79 (5), pp. 1004-1012.

Whitehouse, A.S. and Tisdale, Michael J. (2001). Downregulation of ubiquitin-dependent proteolysis by eicosapentaenoic acid in acute starvation. Biochemical and Biophysical Research Communications, 285 (3), pp. 598-602.

Islam-Ali, B., Khan, S., Price, S.A. and Tisdale, Michael J. (2001). Modulation of adipocyte G-protein expression in cancer cachexia by a lipid-mobilizing factor (LMF). British Journal of Cancer, 85 (5), pp. 758-763.

Lorite, M.J., Smith, Helen J., Arnold, J.A., Morris, A., Thompson, M.G. and Tisdale, Michael J. (2001). Activation of ATP-ubiquitin-dependent proteolysis in skeletal muscle in vivo and murine myoblasts in vitro by a proteolysis-inducing factor (PIF). British Journal of Cancer, 85 (2), pp. 297-302.

Islam-Ali, B.S. and Tisdale, Michael J. (2001). Effect of a tumour-produced lipid-mobilizing factor on protein synthesis and degradation. British Journal of Cancer, 84 (12), pp. 1648-1655.

Whitehouse, A.S., Smith, Helen J., Drake, J.L. and Tisdale, Michael J. (2001). Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid. Cancer Research, 61 (9), pp. 3604-3609.

Barber, Matthew D., Fearon, Kenneth C.H., Tisdale, Michael J., McMillan, Donald C. and Ross, James A. (2001). Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia. Nutrition and Cancer, 40 (2), pp. 118-124.

Belizario, J.E., Lorite, M.J. and Tisdale, Michael J. (2001). Cleavage of caspases-1, -3, -6, -8 and -9 substrates by proteases in skeletal muscles from mice undergoing cancer cachexia. British Journal of Cancer, 84 (8), pp. 1135-1140.

Tisdale, Michael J. (2001). Loss of skeletal muscle in cancer:biochemical mechanisms. Frontiers in Bioscience, 6 , D164-D174.

Book Section

Tisdale, Michael J. (2000). Catabolism of skeletal muscle proteins and its reversal in cancer cachexia. IN: Cancer and nutrition. Mason, J. and Nitenberg, G. (eds) Nestle nutiotion workshop series: clinical and performance program, 4 . Basel (CH): Karger.

This list was generated on Sun Mar 24 01:13:01 2019 GMT.